GlassScriptPhysician profile
Nicole Wax
NPI 1285974097
$724.98
in general payments reported to CMS, 2019-2025
7 companies · $379 in 2025
The $379 reported for 2025 was more than what 78% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).
See the full distribution for Oral and Maxillofacial Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $180 · 2022: $99.51 · 2023: $66.24 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396 · Gift: $49.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.81 |
| Gift | $49.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $243.16 | 2025 | Clarity Aligners, 3m, Apc Flash-Free Victory Series Low Profile |
| Align Technology, INC. | $215.62 | 2020-2025 | Invisalign |
| 3m Company | $107.88 | 2022-2023 | Apc Flash-Free Victory Series Superior Fit, Apc Flash-Free Clarity Advanced, Clarity Aligners |
| American Orthodontics Corporation | $84.00 | 2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Ormco Corporation | $41.94 | 2022 | |
| Envista Holdings Corporation | $16.45 | 2025 | Miniendo II |
| Ortho Organizers, INC. | $15.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Wax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.